186 related articles for article (PubMed ID: 38673967)
1. The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin.
Obregón-Mendoza MA; Meza-Morales W; Rodríguez-Hernández KD; Estévez-Carmona MM; Pérez-González LL; Tavera-Hernández R; Ramírez-Apan MT; Barrera-Hernández D; García-Olivares M; Monroy-Torres B; Nieto-Camacho A; Chávez MI; Sánchez-Obregón R; Enríquez RG
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673967
[TBL] [Abstract][Full Text] [Related]
2. First Gallium and Indium Crystal Structures of Curcuminoid Homoleptic Complexes: All-Different Ligand Stereochemistry and Cytotoxic Potential.
Meza-Morales W; Alvarez-Ricardo Y; Pérez-González LL; Tavera-Hernández R; Ramírez-Apan MT; Toscano RA; Sánchez-Obregón R; Obregón-Mendoza MA; Enríquez RG
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003515
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.
Dandawate PR; Vyas A; Ahmad A; Banerjee S; Deshpande J; Swamy KV; Jamadar A; Dumhe-Klaire AC; Padhye S; Sarkar FH
Pharm Res; 2012 Jul; 29(7):1775-86. PubMed ID: 22322899
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-C3 Complexed with α-, β-cyclodextrin Exhibits Antibacterial and Antioxidant Properties Suitable for Cancer Treatments.
Reddy DNK; Kumar R; Wang SP; Huang FY
Curr Drug Metab; 2019; 20(12):988-1001. PubMed ID: 31573881
[TBL] [Abstract][Full Text] [Related]
5. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
[TBL] [Abstract][Full Text] [Related]
7. Full Structural Characterization of Homoleptic Complexes of Diacetylcurcumin with Mg, Zn, Cu, and Mn: Cisplatin-level Cytotoxicity in Vitro with Minimal Acute Toxicity in Vivo.
Meza-Morales W; Estévez-Carmona MM; Alvarez-Ricardo Y; Obregón-Mendoza MA; Cassani J; Ramírez-Apan MT; Escobedo-Martínez C; Soriano-García M; Reynolds WF; Enríquez RG
Molecules; 2019 Apr; 24(8):. PubMed ID: 31018515
[TBL] [Abstract][Full Text] [Related]
8. Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.
Koroth J; Nirgude S; Tiwari S; Gopalakrishnan V; Mahadeva R; Kumar S; Karki SS; Choudhary B
BMC Complement Altern Med; 2019 Oct; 19(1):273. PubMed ID: 31638975
[TBL] [Abstract][Full Text] [Related]
9. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic and anti-angiogenic properties of potential new anti-cancer drugs based on metal complexes of selenosemicarbazones.
Zec M; Srdic-Rajic T; Konic-Ristic A; Todorovic T; Andjelkovic K; Filipovic-Ljeskovic I; Radulovic S
Anticancer Agents Med Chem; 2012 Nov; 12(9):1071-80. PubMed ID: 22583413
[TBL] [Abstract][Full Text] [Related]
11. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
[TBL] [Abstract][Full Text] [Related]
12. An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity.
Tan Q; Li Y; Wu J; Mei H; Zhao C; Zhang J
Int J Nanomedicine; 2012; 5():5385-93. PubMed ID: 23091376
[TBL] [Abstract][Full Text] [Related]
13. The Molecular Targets and Anti-Invasive Effects of 2,6-bis-(4-hydroxyl-3methoxybenzylidine) cyclohexanone or BHMC in MDA-MB-231 Human Breast Cancer Cells.
Harun SNA; Israf DA; Tham CL; Lam KW; Cheema MS; Md Hashim NF
Molecules; 2018 Apr; 23(4):. PubMed ID: 29642589
[TBL] [Abstract][Full Text] [Related]
14. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin.
Yoon MJ; Kang YJ; Lee JA; Kim IY; Kim MA; Lee YS; Park JH; Lee BY; Kim IA; Kim HS; Kim SA; Yoon AR; Yun CO; Kim EY; Lee K; Choi KS
Cell Death Dis; 2014 Mar; 5(3):e1112. PubMed ID: 24625971
[TBL] [Abstract][Full Text] [Related]
15. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract][Full Text] [Related]
16. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
17. The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells.
Chang CC; Fu CF; Yang WT; Chen TY; Hsu YC
Taiwan J Obstet Gynecol; 2012 Sep; 51(3):368-74. PubMed ID: 23040919
[TBL] [Abstract][Full Text] [Related]
18. The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.
Wang X; Zhang Y; Zhang X; Tian W; Feng W; Chen T
Int J Oncol; 2012 Apr; 40(4):1189-95. PubMed ID: 22179587
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells.
Czarnomysy R; Muszyńska A; Rok J; Rzepka Z; Bielawski K
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070401
[TBL] [Abstract][Full Text] [Related]
20. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
